News
Important Only
Bird Construction Inc reports results for the quarter ended June 30 - Earnings Summary
Bird Construction Inc BDT.TO reported quarterly adjusted earnings of 50 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 42 cents. The mean expectation of seven analysts for the quarter was for earnings of 52 cents per share. ...Reuters
Wed, Aug 13
Global Water Q2 Revenue Up 5.4 Percent
Key PointsRevenue (GAAP) rose 5.4% to $14.2 million, slightly ahead of GAAP estimates of $14.1 million.Earnings per share (GAAP) matched expectations at $0.06, down from $0.07 per share (GAAP) in the prior year.Monthly dividend held steady at $0.02533 per share, annualized to $0.30396 per common sha...The Motley Fool
Wed, Aug 13
Strata Skin Sciences Sales Decline
Key PointsGAAP revenue was $7.7 million for Q2 2025, falling short of the $8.56 million analyst estimate and This result also marked a 9% decline from the prior year.GAAP net loss widened sharply to $2.5 million for Q2 2025, compared to $0.1 million in Q2 2024.Major expansion of reimbursement covera...The Motley Fool
Wed, Aug 13
Why Lemonade Stock Raced More Than 9% Higher Today
Key PointsTwo analysts weighed in with fresh takes on the company.One initiated coverage with a buy, and the other upped his price target.10 stocks we like better than Lemonade › The stock market was hardly sour on Lemonade (NYSE: LMND) stock on Wednesday. On the back of two positive analysts moves ...The Motley Fool
Wed, Aug 13
3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold Forever
Key PointsShares of Merck are down thanks to Keytruda's impending loss of patent protection, but the drugmaker's pipeline is still pretty compelling.There's a chance the economic lethargy that's working against retailer Target is about to dissipate.Snack chip and beverage giant PepsiCo's pronounced ...The Motley Fool
Wed, Aug 13
Ainos Posts Wider Loss in Fiscal Q2
Key PointsNet loss (GAAP) widened to $4.08 million, with operating expenses rising 24% compared to Q2 2024.Cash and cash equivalents fell 68.6% from December 31, 2024, ending the period at $1.22 million as of June 30, 2025.These 10 stocks could mint the next wave of millionaires › Ainos (NASDAQ:AIMD...The Motley Fool
Wed, Aug 13
StandardAero Ups Guidance on Earnings
StandardAero(NYSE:SARO) released results for the fiscal second quarter ended June 30, 2025, on August 13, 2025, revealing revenue grew 13.5% year-over-year to $1.53 billion, and adjusted EBITDA (non-GAAP) rose 20% to $205 million, driving an 80 basis point margin expansion to a 13.4% adjusted EBITDA...The Motley Fool
Wed, Aug 13
DLocal Q2 Profit Jumps on Strong Growth
DLocal(NASDAQ:DLO) reported second-quarter 2025 results on August 13, 2025, with total payment volume (TPV) up 53% year over year to $9.2 billion, revenue up 50% year over year to $256 million, and gross profit up 42% year over year to $99 million. Management raised full-year guidance for both reven...The Motley Fool
Wed, Aug 13
Coherent Posts Record Q4 Revenue
Coherent (NYSE:COHR) reported fiscal fourth quarter ended June 30, 2025, earnings on August 13, 2025, reporting record revenue of $1.53 billion in the fiscal fourth quarter, up 16% year-over-year, and full-year fiscal 2025 revenue of $5.81 billion, up 23% year-over-year, with non-GAAP EPS for fiscal...The Motley Fool
Wed, Aug 13
Ensysce Biosciences Narrows Loss in Q2
Key PointsGAAP EPS loss was narrower than expected at $(0.79) per share for Q2 2025, compared to the estimate of $(1.01).Federal grant income totaled $1.37 million in Q2 2025, with no commercial sales reported.Ensysce Biosciences advanced its PF614 opioid program into Phase 3 in Q3 2025 and achieved...The Motley Fool
Wed, Aug 13
StandardAero, Inc. reports results for the quarter ended June 30 - Earnings Summary
StandardAero, Inc. SARO.N reported quarterly adjusted earnings of 25 cents per share for the quarter ended June 30. The mean expectation of eight analysts for the quarter was for earnings of 23 cents per share. Wall Street expected results to range from 21 cents to 25 cents per share.Revenue was ...Reuters
Wed, Aug 13
Lantern Pharma Narrows Loss in Q2
Key PointsGAAP EPS loss narrowed to ($0.40) per share in Q2 2025, and improving from ($0.46) per share (GAAP) in Q2 2024.Further clinical milestones achieved for core oncology drug candidates, with standout responses in Phase 1 trials.Cash runway maintained through mid‑2026, though no product revenu...The Motley Fool
Wed, Aug 13
Enliven Posts Loss Beat and Cash Surge
Key PointsClinical-stage biotech Enliven Therapeutics (NASDAQ:ELVN) reported a GAAP net loss per share of $(0.49) for Q2 2025, slightly ahead of the estimated $(0.54).Positive Phase 1 clinical results for ELVN-001 in chronic myeloid leukemia, announced in June 2025, compared favorably to historical ...The Motley Fool
Wed, Aug 13
Dyadic International Narrows Q2 Loss
Dyadic International (NASDAQ:DYAI) reported Q2 2025 earnings on August 13, 2025, delivering GAAP revenue of $967,000, representing a year-over-year increase over Q2 2024 and the company’s clearest progress on commercializing its engineered protein platforms to date. Recent operational changes culmin...The Motley Fool
Wed, Aug 13
Applied Therapeutics Reports Q2 Loss
Key PointsGAAP earnings per share of $0.15 beat consensus estimates despite continued operating losses.No revenue (GAAP) was recognized for Q2 2025, down from $0.14 million (GAAP) in Q2 2024.Cash and cash equivalents (GAAP) fell sharply to $30.4 million as of June 30, 2025.These 10 stocks could mint...The Motley Fool
Wed, Aug 13
Ibotta Posts 2 Percent Sales Decline
Key PointsQ2 2025 earnings and revenue fell short of analyst estimates, with GAAP revenue at $86.0 million, down 2% and Adjusted EPS (non-GAAP) was $0.49, compared to the $0.19 estimate.Redeemer growth in the Ibotta Performance Network climbed 27% year-over-year, but direct-to-consumer revenue conti...The Motley Fool
Wed, Aug 13
Allogene Q2 Cash Tops $300 Million
Allogene Therapeutics (NASDAQ:ALLO) reported second-quarter 2025 results on August 13, 2025, highlighting $302.6 million in cash and investments as of the end of Q2 2025 with a projected cash runway into the second half of 2027 despite reporting a GAAP net loss of $50.9 million. The company streamli...The Motley Fool
Wed, Aug 13
